Dr. Noureddin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6445 Main Street
Suite 2200
Houston, TX 77030Phone+1 713-441-4345Fax+1 713-790-3013- Is this information wrong?
Education & Training
- Duke School of MedicineMHSc, Master's Health Sciences in Clinical Research, 2009 - 2018
- University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2011 - 2013
- Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2009 - 2011
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2005 - 2008
- University of Aleppo Faculty of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2007 - 2025
- TX State Medical License 2022 - 2025
- VA State Medical License 2008 - 2012
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Top Doctors Pasadena Magazine 2014-2018
- Visionary in Health Care American Liver Foundation, 2016
Clinical Trials
- The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients Start of enrollment: 2014 Jun 01
- Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- MASH clinical trials and drugs pipeline: An impending Tsunami.Mazen Noureddin> ;Hepatology. 2024 Mar 19
- 1 citationsFrom Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.Wijarnpreecha, K., Danpanichkul, P., Ng, C., Muthiah, M., Suparan, K., Tan, D., Duangsonk, K., Sukphutanan, B., Kongarin, S., Harinwan, N., Panpradist, N., Takahashi, ...> ;The American Journal of Gastroenterology. 2024 Mar 18
- Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting.Alina M Allen, Michael Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook> ;Postgraduate Medicine. 2024 Mar 11
- Join now to see all
Journal Articles
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.Noureddin M1,2, Vipani A3, Bresee C4, Todo T5, Kim IK5, Alkhouri N6, Setiawan VW7, Tran T8,3, Ayoub WS8,3, Lu SC8,3, Klein AS5, Sundaram V8,3, Nissen NN5., American Journal of Gastrenterology, 6/8/2018
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender VariancesTsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
Press Mentions
- Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress™ 2022June 21st, 2022
- Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.January 26th, 2022
- Early Identification of Fatty Liver Using Echosens FibroScan Potentially Gives Payers Five-Year Gross Savings of $10+ Million, Confirmed by Independent StudyDecember 6th, 2021
- Join now to see all
Other Languages
- Arabic, Farsi, Spanish
Hospital Affiliations
- Cedars-Sinai Medical CenterLos Angeles, California
- Houston Methodist HospitalHouston, Texas
- Houston Methodist West HospitalHouston, Texas
External Links
- Houston Methodist Hospitalhttps://www.houstonmethodist.org/doctor/mazen-noureddin/
- Houston Research Institute https://www.houstonresearchinstitute.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: